Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Urology Annals. 2013; 5 (3): 212-214
en Inglés | IMEMR | ID: emr-133069

RESUMEN

Upper urinary tract transitional [UUTT] cell carcinoma is a relatively uncommon urologic tumor. The traditional treatment approach for them is radical nephroureterectomy. However, in recent years, less-invasive treatments, including different nephron-sparing procedures, have become increasingly popular. We report a case of laser ablation of UUTT cell carcinoma using new Olympus digital flexible ureteroscope [URF-V].


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Neoplasias Urológicas , Ureteroscopios , Terapia por Láser , Holmio/uso terapéutico
2.
Korean Journal of Radiology ; : 127-135, 2007.
Artículo en Inglés | WPRIM | ID: wpr-182502

RESUMEN

OBJECTIVE: We wanted to evaluate the effectiveness of intraluminal irradiation with Holmium-166 (166Ho) for reducing the pseudointimal hyperplasia (PIH) in the transjugular intrahepatic portosystemic shunt (TIPS) tract in a swine model. MATERIALS AND METHODS: TIPS was performed in 12 domestic pigs, after the creation of portal hypertension by intraportal injection of a mixture of N-butyl-2-cyanoacrylate (NBCA) and lipiodol. Five pigs first underwent intraluminal irradiation (30 Gy) in the parenchymal tract with using a 166Ho solution-filled balloon catheter, and this was followed by the placement of a nitinol stent in the TIPS tract. For the seven control pigs, the balloon was filled with saline and contrast media mixture. Two weeks later, follow-up portography and histological analysis were performed. RESULTS: TIPS was successfully performed in all twelve pigs with achieving artificially induced portal hypertension. Portography performed two weeks after TIPS showed the patent tracts in the TIPS tracts that were irradiated with 166Ho (5/5, 100%), whereas either completely (5/6, 83.3%) or partially (1/6, 16.7%) occluded TIPS were seen in the seven pigs of the nonirradiated control group, except in one pig that experienced periprocedural death due to bleeding. Histological analysis showed a statistically significant difference for the maximal PIH (irradiated: 32.8%, nonirradiated: 76.0%, p < 0.001) between the two groups. CONCLUSION: Intraluminal irradiation with 30 Gy of 166Ho for TIPS significantly improved the TIPS patency in a swine model of portal hypertension during a 2-week period of follow-up.


Asunto(s)
Animales , Aleaciones , Constricción Patológica/radioterapia , Holmio/uso terapéutico , Hipertensión Portal/terapia , Derivación Portosistémica Intrahepática Transyugular , Radioisótopos/uso terapéutico , Stents , Porcinos
3.
Korean Journal of Radiology ; : 128-133, 2004.
Artículo en Inglés | WPRIM | ID: wpr-182092

RESUMEN

OBJECTIVE: To evaluate the usefulness of a beta-emitting radionuclide (holmium-166-chitosan complex) as a sclerosing agent for the treatment of renal cysts. MATERIALS AND METHODS: Using 10-30 mCi of holmium-166-chitosan complex, 20 renal cysts in 17 patients (14 male and 3 female patients, ranging in age from 47 to 82 years) were treated by percutaneous sclerotherapy under ultrasonographic guidance. The volume of the cysts before and after the sclerotherapy and the percentage change in volume were calculated in order to evaluate the response to therapy, which was classified as either complete regression (invisible), nearly complete regression ( 50 volume%). RESULTS: The follow-up period ranged from 6 to 36 months (mean 28 months). Eighteen cysts (90%) regressed completely (n=11, 55%) or near-completely (n=7, 35%). Partial regression was obtained in one patient (5%) and there was no regression in one patient (5%). No significant complications were encountered. CONCLUSION: The holmium-166-chitosan complex seems to be useful as a new painless sclerosing agent for the treatment of renal cysts with no significant complications.


Asunto(s)
Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Quitina/análogos & derivados , Holmio/uso terapéutico , Enfermedades Renales Quísticas/radioterapia , Compuestos Organometálicos/uso terapéutico , Radiofármacos/uso terapéutico , Escleroterapia
4.
Rev. ABO nac ; 2(3): 203-4, 206-7, jun.-jul. 1994. ilus
Artículo en Portugués | LILACS, BBO | ID: lil-155742

RESUMEN

O raio laser chega como a informática. A principio, visto com resistência. Depois, vira milagroso para os mais sonhadores. A verdade é que a onda bombardeia para valer. Resolve e tem inúmeras aplicaçöes na Odontologia


Asunto(s)
Rayos Láser/efectos adversos , Rayos Láser/uso terapéutico , Restauración Dental Permanente/tendencias , Holmio/uso terapéutico , Neodimio/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA